Louise E Ramm Selected Research

Iron

1/2023	The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.
1/2021	Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
11/2020	Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
1/2020	Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
12/2019	Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
12/2017	Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
8/2015	Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louise E Ramm Research Topics

Disease

12	Fibrosis (Cirrhosis) 01/2023 - 02/2009
9	Hemochromatosis (Bronze Diabetes) 01/2023 - 02/2009
4	Cystic Fibrosis (Mucoviscidosis) 01/2023 - 11/2015
4	Liver Diseases (Liver Disease) 01/2023 - 11/2015
3	Iron Overload 11/2020 - 08/2015
2	Arthritis (Polyarthritis) 01/2022 - 08/2015
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Hyperferritinemia 12/2017
1	Fatigue 08/2015

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2009
7	IronIBA 01/2023 - 08/2015
7	Ferritins (Ferritin)IBA 01/2023 - 02/2009
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 02/2009
1	HLA-A3 Antigen (HLA A3 Antigen)IBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	HLA-B7 Antigen (HLA B7 Antigen)IBA 01/2023
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	TransferasesIBA 01/2021
1	AcyltransferasesIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Transferrin (beta 2 Transferrin)IBA 12/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 08/2015
1	F2-Isoprostanes (F2 Isoprostanes)IBA 08/2015
1	Hyaluronic Acid (Hyaluronan)IBA 02/2009
1	Collagen Type IV (Type IV Collagen)IBA 02/2009

Therapy/Procedure

1	Therapeutics 01/2023
1	Aftercare (After-Treatment) 01/2020